Family Medicine Doctors in Flanders, NJ Accepting Medicare

2 Family Medicine doctors found. Showing 1 - 2

Samuel Friedman, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 183 Route 206 Ste 1, Flanders, NJ 07836 Phone: 973-347-3277    Fax: 973-347-3141

Dr. Chen Ya Huang, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 270 Highway 206, Flanders, NJ 07836 Phone: 973-584-0233    Fax: 973-584-0037

News Archive

Ranbaxy receives FDA approval to market Loratadine and Pseudoephedrine Sulfate extended release tablets

Ranbaxy Pharmaceuticals, a wholly-owned subsidiary of Ranbaxy Laboratories Limited of New Delhi, India, announced today that RLL has received approval from the U. S. Food and Drug Administration to manufacture and market Loratadine and Pseudoephedrine Sulfate Extended Release Tablets

Immunotherapy shows promise in treatment of Type 1 diabetes

Around 1.25 million Americans are living with type 1 diabetes and 40,000 new cases are detected each year. In this condition body's own immune system attacks and damages the insulin-producing β-cells inside the pancreas leading to impaired glucose metabolism in the body. There is no other treatment for this condition than regular painful insulin injections to maintain the normal insulin levels in the body. Type 1 diabetes is currently considered to be incurable.

Palm Beach County, Fla., commissioners approve plan to reduce HIV/AIDS services by $600,000 in 2009

The Palm Beach County, Fla., commissioners have approved a plan to reduce funding for food and medical case management services for people living with HIV/AIDS by $600,000 in 2009, Larry Leed of the Palm Beach County HIV CARE Council announced on Tuesday, the Palm Beach Post reports. According to the Post, the decision is in response to the continued decrease in Ryan White Program funding.

Orexo announces successful completion of OX219 initial pharmacokinetic trial for opioid dependence

Orexo AB announces successful completion of the initial pharmacokinetic trial in the OX219 project. In the comparative bioavailability study, the OX219 buprenorphine/naloxone sublingual tablet formulation demonstrated favourable profiles compared to the comparator Suboxone®, which is the market leading product for treatment of opioid dependence.

Read more Medical News

› Verified 1 days ago